Home/Filings/4/0001844320-26-000002
4//SEC Filing

Schlosser Mario 4

Accession 0001844320-26-000002

CIK 0001568651other

Filed

Jan 5, 7:00 PM ET

Accepted

Jan 6, 4:18 PM ET

Size

20.0 KB

Accession

0001844320-26-000002

Insider Transaction Report

Form 4
Period: 2026-01-02
Schlosser Mario
DirectorPresident of Technology & CTO
Transactions
  • Conversion

    Class A Common Stock

    2026-01-02+59,800498,148 total
  • Sale

    Class A Common Stock

    2026-01-02$15.02/sh137,933$2,071,754360,215 total
  • Conversion

    Class A Common Stock

    2026-01-05+86,893447,108 total
  • Sale

    Class A Common Stock

    2026-01-05$15.64/sh96,928$1,515,954350,180 total
  • Conversion

    Class B Common Stock

    2026-01-0259,8001,619,186 total
    Class A Common Stock (59,800 underlying)
  • Conversion

    Class B Common Stock

    2026-01-0586,8931,532,293 total
    Class A Common Stock (86,893 underlying)
Holdings
  • Class B Common Stock

    (indirect: By Trust)
    Class A Common Stock (333,333 underlying)
    333,333
  • Class B Common Stock

    (indirect: By Trust)
    Class A Common Stock (633,333 underlying)
    633,333
  • Class B Common Stock

    (indirect: By Trust)
    Class A Common Stock (333,333 underlying)
    333,333
Footnotes (5)
  • [F1]The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on September 23, 2025.
  • [F2]The Class B common stock is convertible at any time at the option of the holder into Class A common stock on a one-to-one basis, subject to certain exceptions, and will mandatorily convert into Class A common stock on the date that is seven years from the date of the prospectus used in connection with the Issuer's initial public offering and upon the occurrence of certain events as set forth in the Issuer's certificate of incorporation.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  • [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.42 to $15.84, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  • [F5]Mr. Schlosser disclaims beneficial ownership over the shares held of record by the trust except to the extent of his pecuniary interest therein, if any.

Issuer

Oscar Health, Inc.

CIK 0001568651

Entity typeother

Related Parties

1
  • filerCIK 0001844320

Filing Metadata

Form type
4
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:18 PM ET
Size
20.0 KB